SLC5A2 and type 2 diabetes mellitus: In a retrospective cohort study, using administrative health care data from Canada and a primary care clinical database from the United Kingdom (the Clinical Practice Research Datalink), a cohort of over 350,000 adults with T2DM who received an SGLT2-i or a DPP4-i and more than 500 DKA events were identified.